FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

413382007: Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    3501987012 Abacavir 600 mg and lamivudine 300 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    3676205019 Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    46857401000001116 Abacavir 600mg / Lamivudine 300mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Is a Product containing abacavir and lamivudine false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient Lamivudine false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient Abacavir false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Is a Product containing abacavir and lamivudine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient Lamivudine false Inferred relationship Existential restriction modifier 1
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance Lamivudine false Inferred relationship Existential restriction modifier 1
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier 1
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient Abacavir false Inferred relationship Existential restriction modifier 2
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance Abacavir false Inferred relationship Existential restriction modifier 2
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator value 600 false Inferred relationship Existential restriction modifier 2
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 2
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has precise active ingredient Abacavir false Inferred relationship Existential restriction modifier 2
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has precise active ingredient Lamivudine false Inferred relationship Existential restriction modifier 1
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Is a Product containing only abacavir and lamivudine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient Abacavir false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient Lamivudine false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has active ingredient Abacavir sulfate false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Abacavir false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has specific active ingredient Lamivudine false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has specific active ingredient Abacavir sulfate false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has specific active ingredient Abacavir false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has basis of strength substance Abacavir false Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Abacavir 600mg / Lamivudine 300mg tablets (Zentiva Pharma UK Ltd) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Kivexa 600mg/300mg tablets (GlaxoSmithKline) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets 30 tablet Is pack of False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets (Sun Pharmaceutical Industries Europe B.V.) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets 30 tablet Has VMP False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets (Teva UK Ltd) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets (A A H Pharmaceuticals Ltd) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets (Viatris UK Healthcare Ltd) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets (Lupin (Europe) Ltd) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Abacavir 600mg / Lamivudine 300mg tablets (Dr Reddy's Laboratories (UK) Ltd) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Kivexa 600mg/300mg tablets (Originalis B.V.) Is a False Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start